Antipsychotic long-acting injections (Record no. 30682)

MARC details
000 -LEADER
fixed length control field 02137nam a2200277 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150908e201603uuxxk | |||||||0|0 eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780198729471 (pbk.) :
Terms of availability £34.99
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0198729472 (pbk.) :
Terms of availability £34.99
040 ## - CATALOGING SOURCE
Original cataloging agency UK-WkNB
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WM 402.
245 10 - TITLE STATEMENT
Title Antipsychotic long-acting injections
250 ## - EDITION
Edition statement 2nd ed.
260 ## - PUBLICATION INFORMATION
Place of publication Oxford :
Publisher Oxford University Press,
Date 2016.
300 ## - PHYSICAL DESCRIPTION
Physical description xxi, 366 p. ;
520 ## - ABSTRACT
Abstract Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon.<br/><br/>The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research.<br/><br/>Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.
650 ## - SUBJECT HEADINGS
Subject term Psychotic disorders
650 ## - SUBJECT HEADINGS
Subject term Psychoses
650 ## - SUBJECT HEADINGS
Subject term Schizophrenia
650 ## - SUBJECT HEADINGS
Subject term Antipsychotic drugs
9 (RLIN) 5245
650 ## - SUBJECT HEADINGS
Subject term Drug therapy
650 ## - SUBJECT HEADINGS
Subject term Psychopharmacology
700 1# - ADDED PERSONAL NAME
Added personal author Haddad, Peter
Relator term editor
700 1# - ADDED PERSONAL NAME
Added personal author Lambert, Tim
Relator term editor
700 1# - ADDED PERSONAL NAME
Added personal author Lauriello, John
Relator term editor
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Date last borrowed Cost, replacement price Price effective from Koha item type
    National Library of Medicine     South London and Maudsley Trust Library South London and Maudsley Trust Library Shelves 01/04/2016 9 26.25 2 WM 402 ANT 022520 23/03/2017 17/03/2017 35.00 01/04/2016 Book
London Health Libraries Koha Consortium privacy notice